Low molecular weight heparin promotes the PPAR pathway by protecting the glycocalyx of cells to delay the progression of diabetic nephropathy

被引：0

作者：

Zhang, Bin ^{[1
]}

Bu, Changkai ^{[1
]}

Wang, Qingchi ^{[1
]}

Chen, Qingqing ^{[1
]}

Shi, Deling ^{[1
]}

Qiu, Hongyan ^{[2
]}

Wang, Zhangjie ^{[3
]}

Liu, Jian ^{[3
]}

Wang, Zhe ^{[4
,5
]}

Zhang, Qunye ^{[6
,7
,8
]}

Chi, Lianli ^{[1
]}

机构：

[1] National Glycoengineering Research Center, Shandong University, Shandong, Qingdao, China

[2] Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Shandong, Weifang, China

[3] Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill,NC, United States

[4] Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

[5] Department of Endocrinology & Geriatrics, Shandong Provincial Hospital, Shandong University, Jinan, China

[6] National Key Laboratory for Innovation and Transformation of Luobing Theory, Shandong, Jinan, China

[7] The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Shandong, Jinan, China

[8] Department of Cardiology, Qilu Hospital of Shandong University, Shandong, Jinan, China

来源：

Journal of Biological Chemistry | 2024年 / 300卷 / 08期

关键词：

51;

D O I：

10.1016/j.jbc.2024.107493

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN IN EXPERIMENTAL DIABETIC NEPHROPATHY
OTURAI, PS
KOFOEDENEVOLDSEN, A
DECKERT, T
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1045 - 1045
[2] Low birth weight a progression promoter in diabetic nephropathy?
Jacobsen, P
Rossing, P
Tarnow, L
Nielsen, FS
Hansen, BV
Brenner, BM
Parving, HH
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0569 - A0569
[3] Low birth weight - A progression promoter in diabetic nephropathy?
Jacobsen, P
Rossing, P
Tarnow, L
Rossing, K
Nielsen, FS
Hansen, BV
Brenner, BM
Parving, HH
[J]. DIABETOLOGIA, 1997, 40 : 2105 - 2105
[4] LOW MOLECULAR WEIGHT HEPARIN DECREASES THE ALBUMINURIA AND RENAL PATHOLOGICAL CHANGES IN DIABETIC NEPHROPATHY RATS
王锋
邢涛
汪年松
晏春根
[J]. Medical Bulletin of Shanghai Jiaotong University, 2010, 22 (02) : 66 - 70
[5] Treatment of diabetic nephropathy with low-molecular heparin - Sulodexide
Zalevskaya, AG
Astamirova, KS
Karpova, IA
Popova, SG
[J]. TERAPEVTICHESKII ARKHIV, 1998, 70 (03): : 71 - 74
[6] Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin
Lipowsky, Herbert H.
Lescanic, Anne
[J]. MICROVASCULAR RESEARCH, 2017, 112 : 72 - 78
[7] A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice Independently of the Endothelial Glycocalyx
Van Sluis, Geerte L.
Nieuwdorp, Max
Kamphuisen, Pieter W.
van der Vlag, Johan
Van Noorden, Cornelis J. F.
Spek, C. Arnold
[J]. PLOS ONE, 2010, 5 (06):
[8] Efficacy of sulodexide, low-molecular heparin, in therapy of diabetic nephropathy
Shestakova, MV
Chugunova, LA
Vorontsov, AV
Dedov, II
[J]. TERAPEVTICHESKII ARKHIV, 1997, 69 (06): : 34 - 37
[9] Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy Implications for the therapeutic use of low-molecular weight heparin
Lewis, Edmund J.
Xu, Xiulong
[J]. DIABETES CARE, 2008, 31 : S202 - S207
[10] Treatment failure of low molecular weight heparin in diabetic patient
Tulino, D.
Imbalzano, E.
Casale, M.
D'Angelo, M.
Coglitore, S.
Di Bella, G.
Dattilo, G.
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : E63 - E64

← 1 2 3 4 5 →